Renoprotective Effects Of Empagliflozin In Patients With Acute Myocardial Infarction And Type 2 Diabetes Mellitus; Subgroup Analysis Of The Embody Trial
Circulation(2020)
摘要
Introduction: Although renoprotective effect of sodium glucose co-transporter-2 (SGLT2) inhibitors has been recognized in the patients with heart failure or type 2 diabetes mellitus (T2DM), this pr...
更多查看译文
关键词
empagliflozin,myocardial infarction,acute myocardial infarction,diabetes mellitus
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要